Alpharma’s Flector NSAID Patch Off To A Strong Start, CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
First topical NSAID patch garners 3,800 scripts in its first two weeks on the market.
You may also be interested in...
King Makes Play For Alpharma To Build Specialty Pain Franchise
Alpharma declines offer; King expresses hope for amicable resolution.
King Makes Play For Alpharma To Build Specialty Pain Franchise
Alpharma declines offer; King expresses hope for amicable resolution.
Alpharma Submits Embeda Abuse-Deterrent Morphine Capsule To FDA
Company files NDA slightly ahead of potential competitor Remoxy, in development by Pain Therapeutics.